Last update 06 Sep 2025

Ex vivo expanded CD34+ hematopoietic stem cells(University of Florida)

Overview

Basic Info

Drug Type
Hematopoietic stem cell therapy
Synonyms
exHSCs(University of Florida)
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication
EpendymomaGlioblastomaMixed oligoastrocytoma+ [2]
Inactive Indication-
Originator Organization
University of FloridaUniversity of Florida
Active Organization
University of FloridaUniversity of Florida
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Ex vivo expanded CD34+ hematopoietic stem cells(University of Florida)
NCT07031765
/ RecruitingPhase 1IIT
Peds CHAMP1ON - Combinatorial Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade Phase 1 Trial for RecurreNt Pediatric High-Grade Glioma
100 Clinical Results associated with Ex vivo expanded CD34+ hematopoietic stem cells(University of Florida)
Login to view more data
100 Translational Medicine associated with Ex vivo expanded CD34+ hematopoietic stem cells(University of Florida)
Login to view more data
100 Patents (Medical) associated with Ex vivo expanded CD34+ hematopoietic stem cells(University of Florida)
Login to view more data
100 Deals associated with Ex vivo expanded CD34+ hematopoietic stem cells(University of Florida)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EpendymomaPhase 1
United States
University of FloridaUniversity of Florida
25 Jul 2025
GlioblastomaPhase 1
United States
University of FloridaUniversity of Florida
25 Jul 2025
Mixed oligoastrocytomaPhase 1
United States
University of FloridaUniversity of Florida
25 Jul 2025
OligodendrogliomaPhase 1
United States
University of FloridaUniversity of Florida
25 Jul 2025
Recurrent Malignant GliomaPhase 1
United States
University of FloridaUniversity of Florida
25 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free